• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Dermatology

Category Archive

  • Dermatology / February 4, 2021

    News on infantile haemangioma. Part 2: therapy and evaluation.

    View Post
  • Dermatology / April 6, 2021

    Reconstructive options for cutaneous dorsal hand defects.

    View Post
  • Dermatology / February 5, 2021

    Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma.

    View Post
  • Dermatology / February 27, 2021

    Chloracne: a case series on cutaneous expression of CYP1A1 as diagnostic biomarker.

    View Post
  • Dermatology / May 9, 2021

    Comorbidities, Mortality and Survival in Patients with Pyoderma Gangrenosum: A Danish Nationwide Registry-Nested Case-Control Study.

    View Post

Establishing the efficacy and safety of the novel use of common salt for the treatment of pyogenic granuloma.

In Dermatology
by ClinOwl
March 25, 2021

Recurrent bleeding episodes are often a cause of significant anxiety in patients with pyogenic granuloma. The idea of using common salt for the treatment of pyogenic granuloma arose from the …

Ocular and auditory abnormalities in vitiligo patients: A case- control study.

In Dermatology
by ClinOwl
March 25, 2021

Vitiligo is characterized by the destruction of functional melanocytes in the skin. This destruction could target melanocytes anywhere in the body, which could affect function of organs where they reside. …

Refinement and Validation of the ItchyQoL using Classical Test Theory and Item Response Theory resulted in a reduction of the response categories from a 5-point to a 3-point scale.

In Dermatology
by ClinOwl
March 25, 2021

The ItchyQoL is an itch-specific patient-reported outcome measure (PROM) assessing quality of life (QoL) in patients with chronic pruritus (CP). We aimed to assess and extend the psychometric properties of …

Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision ± radiation therapy with no increase in MCC-specific death.

In Dermatology
by ClinOwl
March 24, 2021

Merkel cell carcinoma (MCC) of the skin is most commonly treated with wide local excision (WLE) with or without adjuvant radiation therapy (RT). Mohs micrographic surgery (MMS) as monotherapy may …

Toxic Epidermal Necrolysis Like Lupus – A Case Series.

In Dermatology
by ClinOwl
March 24, 2021

Extensive epidermal loss is not a commonly recognised presentation of acute cutaneous lupus; however, when it does occur, it can be life-threatening and mimic Stevens Johnson Syndrome or Toxic Epidermal …

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results.

In Dermatology
by ClinOwl
March 24, 2021

Alopecia areata (AA) is an autoimmune form of hair loss with limited treatments.To evaluate the efficacy and safety of the Janus kinase inhibitors ritlecitinib and brepocitinib in patients with AA …

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.

In Dermatology
by ClinOwl
March 24, 2021

The oral Janus kinase 1 (JAK1) inhibitor abrocitinib, which reduces interleukin-4 and interleukin-13 signaling, is being investigated for the treatment of atopic dermatitis. Data from trials comparing JAK1 inhibitors with …

Diagnosis and management of morphoea in children: an overview.

In Dermatology
by ClinOwl
March 23, 2021

Paediatric morphoea (localized scleroderma) is an inflammatory sclerosing disorder of the skin and subcutis associated with tissue atrophy. It is thought that the disease develops on the background of genetic …

Occupational Contact Dermatitis: Retrospective Analysis of North American Contact Dermatitis Group Data, 2001 to 2016.

In Dermatology
by ClinOwl
March 23, 2021

Patch-testing is an important diagnostic tool for suspected allergic contact dermatitis (ACD) in occupational settings.Provide an overview of occupational skin disease (OSD) and analysis of occupational ACD in North American …

Clinical mimickers of calciphylaxis: a retrospective study.

In Dermatology
by ClinOwl
March 21, 2021

Calciphylaxis is an ischemic vasculopathy with high morbidity and mortality. Early and accurate diagnosis is critical to management of calciphylaxis, and clinical mimickers may contribute to delayed or misdiagnosis.To assess …

  • Page 20 of 57
  • ←
  • 1
  • ...
  • 19
  • 20
  • 21
  • ...
  • 57
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer